Navigation Links
Shire Continues to Deliver Excellent Growth From Core Products
Date:10/30/2009

91% of total revenues (2008: 92%). Excluding ADDERALL XR, product sales from core products increased by 20% to $531.6 million (2008: $443.8 million).

    Product Highlights

                                                                          US
                                                                     Average
                                                     CER     US Rx  Quarterly
                                         Sales  Growth(2) Growth(1)   Market
    Product                 Sales $M  Growth(2)       (3)       (2)  Share(1)
    Specialty
    Pharmaceuticals
    VYVANSE                    129.0       34%       34%       57%       13%
    DAYTRANA                    17.4       -4%       -4%      -12%        1%
    EQUASYM                      9.2       n/a       n/a    n/a(5)    n/a(5)
    LIALDA / MEZAVANT           65.4       62%       63%       34%       17%
    PENTASA                     51.3        4%        4%       -3%       16%
    FOSRENOL                    47.7       11%       14%       -3%        8%
    XAGRID(R)                   21.5       11%       18%    n/a(5)    n/a(5)

    ADDERALL XR                 70.9      -74%      -74%      -59%        8%

    Human Genetic Therapies
    ELAPRASE                    90.9       16%       20%    n/a(4)    n/a(4)
    REPLAGAL                    48.3        8%       15%    n/a(5)    n/a(5)
    FIRAZYR                      1.8         -         -    n/a(5)    n/a(5)

    (1) Product specific prescription data is provided by IMS Health ("IMS")
        National Prescription Audit, a leading global provider of business
        intelligence for the pharmaceutical and healthcare industries. All
        other US market share data stated in the text below is also provided
        by IMS.
    (2) Compared to Q3 2008.
    (3) CER growth, which is a Non GAAP measure, is calculated after
        restating Q3 2009 results using Q3 2008 average foreign exchange
        rates.
    (4) I
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)...  A substantial share of pharmacy and therapeutics ... are included in formularies—say patient support resources from ... Manhattan Research study, Taking the Pulse® Formulary ... P&T committee members in hospitals, managed care organizations ... a high bar for these programs, requiring that ...
(Date:7/31/2014)... FRANCISCO , July 31, 2014 ... and Aspira Scientific ( Milpitas, California ... venture to develop and commercialize new fluorination products ... active molecules has benefited from the use of ... and combine lipophilicity with polarity to improve binding ...
(Date:7/31/2014)... , July 31, 2014 For the ... can watch the implantation of the SynCardia temporary Total ... and matching video posted on the Journal of Visualized ... and read the paper on the SynCardia Total Artificial ... 16-minute video accompanies "Implantation of the SynCardia Total Artificial ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
... N.J. and EDISON, N.J., June 8, 2011 ... they had entered into a broad-based collaboration agreement ... products. Under the terms of the agreement, AustarPharma ... manufacture products for Amerigen to commercialize in the ...
... Hospital ORs and ASCs (ambulatory surgery centers) face staffing ... to delegate non-care related tasks such as instrument purchasing ... Surgical, a 20+-year provider of high-quality specialty surgical ... an informed supply partner: Surgical instruments have ...
Cached Medicine Technology:Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products 2Millennium Surgical's Smart Instrument Purchasing Saves OR Personnel Time, Money 2
(Date:8/1/2014)... 2014 Surftech athletes Jack Bark and ... World Championships this past weekend in Hawaii in commanding ... finisher Zeb Walsh were all on stock Surftech Bark ... race and athletes this year were treated to 6-10 ... course extremely challenging as well as very fast. ...
(Date:8/1/2014)... 01, 2014 iFitDress.com, a professional company ... new collection of 2014 silver bridesmaid dresses ... according to the latest fashion trends. What’s more, they ... 55 percent off. , iFitDress.com is one of ... in not only silver bridesmaid gowns, but also many ...
(Date:7/31/2014)... 2014) Women over the age of 65 face ... obesity, greater struggles against poverty and higher rates of ... the August issue of Annals of Allergy, Asthma ... College of Allergy, Asthma and Immunology (ACAAI), outlines the ... offers practical solutions to improve their care. ...
(Date:7/31/2014)... Developer Jamestown, L.P., has been using ... City Market project in Atlanta’s Old Fourth Ward, which ... building into best-in-class office, housing, and retail spaces. As ... with their construction webcam service to assess how it ... construction camera for monitoring and documentation purposes, ...
(Date:7/31/2014)... 31, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
Breaking Medicine News(10 mins):Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... linked to iron deficiency, intravenous administration of iron increases ... says a Turkish study. ,Since oral iron replacement ... first choice for treatment for iron-deficiency anemia, Dr. Ragip ... it seems that intravenous iron sucrose is a safe ...
... 'small is good' and those small portions help us keep over ... pour 20-30% more alcohol // into short , wide glasses than ... believe that tall glasses hold more. The study finds mention ... public but seasoned and professional bartenders do the same mistake or ...
... of Jharkhand has given health the status of industry. ... to receive all facilities provided under the industrial policy. ... and infrastructure support. ,The government move is ... the health sector in state, where half the population ...
... Woods with other scientists from British Cardiac Society, ... the Primary Care Cardiovascular Society // and ... preventing cardiovascular risks of heart attacks, stroke and ... drafted to reduce the risk of developing heart ...
... of Medicine in St. Louis has found that survivors of ... as depressed as some studies make them out to be ... December issue of Supportive Care in Cancer. ,This study ... Center at Washington University School of Medicine and Barnes-Jewish Hospital. ...
... in the December 21 issue of the Journal of the ... radiation reduces the ability // to repair the chromosomal damage ... developing basal cell carcinoma and squamous cell carcinoma. ... is responsible for breaking DNA strands in exposed skin cells. ...
Cached Medicine News:Health News:Intravenous Iron treats anemia of pregnancy faster 2
... personal-sized Thermal Cycler is the ideal instrument for ... range of PCR applications. Get Applied ... Save lab space without sacrificing results. ... Industry-Standard PCR Technology You Can Afford ...
... Mastercycler ep Extremely fast heating and ... technology Intuitive graphic programming Can be ... system, or a PC-controlled network Heated lid ... Optional motorized lid for integration into fully ...
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
Medicine Products: